Clincosm LogoSign in Get a demo

myeloproliferative disorders

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Dysregulated Signaling in MPD Via Multiparameter

Terminated
  • Myeloproliferative Disorders
  • Myeloproliferative Disorders (MPD)
    • Stanford, California
      Stanford University School of Medicine
    Apr 7, 2020

    Neural Tube Defects, Anemia, Leukemia, Myeloid Trial in Stanford (CIK cells, Cyclosporine, Mycophenolate Mofetil)

    Completed
    Has Results
    • Neural Tube Defects
    • +5 more
    • CIK cells
    • +4 more
    • Stanford, California
      Stanford University School of Medicine
    Apr 18, 2019

    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic

    Completed
    Has Results
    • Leukemia
    • +2 more
    • Allogeneic bone marrow transplantation
    • Peripheral blood stem cell transplantation
    • Birmingham, Alabama
    • +44 more
    Oct 24, 2017

    B-Receptor Signaling in Cardiomyopathy

    Completed
    • Carcinomas
    • +37 more
      • Stanford, California
        Stanford University School of Medicine
      Nov 16, 2015

      Myeloproliferative Disorders, Blood Cancer, MDS Trial in Stanford (Total Lymphoid Irradiation (TLI), Anti-Thymocyte Globulin as

      Completed
      • Myeloproliferative Disorders
      • +2 more
      • Total Lymphoid Irradiation (TLI)
      • Anti-Thymocyte Globulin as Conditioning (ATG)
      • Stanford, California
        Stanford University School of Medicine
      Mar 16, 2015

      Acute Disease, MDS, Leukemia, Myeloid, Chronic Trial in Stanford (ablative allogeneic hematopoietic cell transplantation)

      Completed
      • Acute Disease
      • +6 more
      • ablative allogeneic hematopoietic cell transplantation
      • Stanford, California
        Stanford University School of Medicine
      Dec 13, 2012

      MDS, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT) Trial in Stanford (nonmyeloablative allogeneic

      Completed
      • Myelodysplastic Syndromes
      • +4 more
      • nonmyeloablative allogeneic hematopoietic cell transplant
      • Stanford, California
        Stanford University School of Medicine
      Oct 13, 2010